Clinical Trials Browser

Phase 2 × marizomib × Clear all

NCT05050305 2024-07-16

Marizomib Central Nervous System (CNS)

Phase 2 Withdrawn

Multiple Myeloma

NCT00461045 2017-12-19

Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Phase 2 Completed

15 enrolled 20 charts

Multiple Myeloma, Recurrence